Kaylee Nordholm, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4016 9th St, Rock Island, IL 61201 Phone: 309-786-6474 |
Takesha Mcnamee, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4016 9th St, Rock Island, IL 61201 Phone: 309-786-6474 |
Betty Hatley, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4016 9th St, Rock Island, IL 61201 Phone: 309-786-6474 |
Maya Mikkia Bradford, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2701 17th St, Rock Island, IL 61201 Phone: 309-779-2031 |
Allyson Chantell Quick, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1522 9th St, Rock Island, IL 61201 Phone: 309-912-4425 |
Cheryl Cole, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4016 9th St, Rock Island, IL 61201 Phone: 309-786-6474 |
Judy Bowers, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4016 9th St, Rock Island, IL 61201 Phone: 309-786-6474 |
Teresa Christi Sutton, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3207 24th St, Rock Island, IL 61201 Phone: 309-235-3861 |
News Archive
While the percentage of obese children in the United States tripled between the early 1970s and the late 2000s, a new study suggests that-at least for middle school students-weight gain has nothing to do with the candy, soda, chips, and other junk food they can purchase at school.
Trials done in over 7,000 people prove conclusively that antibiotics could prevent deaths in intensive care units, but many hospitals aren't using them because of unproven fears that it might increase antibiotic resistance.
Anacor Pharmaceuticals, Inc. and Medicis Pharmaceutical Corporation today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the potential treatment of acne.
Lenetix, Inc. today announced a significant step in the development of an improved first and second trimester non-invasive fetal chromosomal screening test to detect Down syndrome and other genetic fetal conditions.
› Verified 2 days ago